Genus plc (GNS), the global animal genetics and breeding technology company, has confirmed the repurchase and cancellation of 165,820 ordinary shares between 26 October 2026 and 30 October 2026. The shares were acquired through J.P. Morgan Securities plc in a series of daily market transactions, with all purchased shares set to be cancelled rather than held in treasury. The disclosure was made in accordance with UKLR 9.6.6R, the UK Listing Rules requirement governing companies reporting transactions in their own securities.

Key Points

  • Genus plc (GNS) — global animal genetics and breeding technology group listed on the London Stock Exchange
  • Genus purchased a total of 165,820 ordinary shares of 10 pence each across five trading days, with all shares to be cancelled
  • Volume weighted average prices ranged from 2,296.6391 pence on 29 October to 2,338.9712 pence on 27 October 2026
  • Investors may be watching for any further buyback tranches and any update to the total shares in issue following cancellation

Genus Buys Back 165,820 Shares for Cancellation via J.P. Morgan Securities

Genus plc confirmed that J.P. Morgan Securities plc acted as its broker for the repurchase programme during the five-day window from 26 October to 30 October 2026. Each day saw purchases ranging from 31,763 shares on 27 October to 35,437 shares on 26 October. All 165,820 ordinary shares of 10 pence each will be cancelled, meaning they will no longer form part of the company's issued share capital. Cancellation, rather than treasury retention, directly reduces the total number of shares in issue, which can affect earnings-per-share calculations for investors monitoring Genus's financial metrics.

Daily Price Range Shows Transactions Executed Between 2,282p and 2,356p

The announcement provides a detailed daily breakdown of purchase prices. The lowest price paid across the entire period was 2,282.0000 pence, recorded on both 26 October and 29 October 2026, while the highest price paid was 2,356.0000 pence on 27 October 2026. Volume weighted average prices moved within a relatively narrow band, from 2,296.6391 pence on 29 October to 2,338.9712 pence on 27 October. The total value of the buyback was not disclosed as a single aggregate figure in the announcement, and the company did not disclose this figure in the announcement.

Regulatory Compliance Under UKLR 9.6.6R and UK Market Abuse Framework

The disclosure is made pursuant to UKLR 9.6.6R and Article 5(1)(b) of Regulation (EU) No 596/2014, which forms part of UK domestic law via the European Union (Withdrawal) Act 2018 as amended. These rules require listed companies to publish detailed information on own-share transactions to maintain market transparency. Genus has also provided a link to disaggregated trade-level data via the London Stock Exchange's RNS-PDF service, allowing investors and analysts to examine individual transaction details. Genus operates in the animal genetics sector, providing bovine and porcine breeding solutions to agricultural markets globally.